CircVMP1 promotes glycolysis and disease progression by upregulating HKDC1 in colorectal cancer
Authors:
- 27 November 2023
- journal article
- research article
- Published by Wiley in Environmental Toxicology
- Vol. 39 (3) , 1617-1630
Abstract
Background: Circular RNAs (circRNAs) have been reported to play important roles in cancers. Here, we characterized circVMP1 (hsa_circ_0006508), an important circRNA which promoted glycolysis and disease progression in colorectal cancer (CRC). In this study, we aimed to explore the mechanism by which circVMP1 regulated tumor glycolysis and its related pathways in promoting CRC cell proliferation and metastasis. Methods: The expression level of circVMP1 in CRC tissues and adjacent normal tissues was detected using quantitative PCR. In vitro and in vivo functional experiments were used to evaluate the effects of circVMP1 in the regulation of CRC cell proliferation and migration. Mitochondrial stress tests and glycolysis stress tests were conducted to detect the effect of circVMP1 on oxidative phosphorylation and glycolysis. Dual‐luciferase reporter and RNA immunoprecipitation assays were used to evaluate the interaction between circVMP1, miR‐3167, and HKDC1. Results: We demonstrated that the level of circVMP1 was significantly upregulated in CRC tissues compared with normal tissues. In HCT116 and SW480 cells, overexpression of circVMP1 promoted proliferation, metastasis, and glycolysis. In vivo analysis indicated that circVMP1 accelerated the proliferation of xenograft tumors. As for the mechanism, overexpression of circVMP1 increased the levels of hexokinase domain component 1 (HKDC1) through competitive binding with miR‐3167. Conclusion: Our study reported that circVMP1 was one of the tumor driver genes that promoted CRC malignant progression and glycolysis by upregulating HKDC1. CircVMP1/miR‐3167/HKDC1 was a signaling axis that might be a target for CRC therapy.Keywords
Funding Information
- National Natural Science Foundation of China (8180235)
This publication has 27 references indexed in Scilit:
- Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancerCancer Letters, 2018
- Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?Nature Reviews Cancer, 2016
- Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosisLaboratory Investigation, 2016
- Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratoryAnnals of Oncology, 2016
- The biogenesis and emerging roles of circular RNAsNature Reviews Molecular Cell Biology, 2016
- Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically ExpressedMolecular Cell, 2015
- Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapyDrug Resistance Updates, 2015
- Adaptation to hypoxia and acidosis in carcinogenesis and tumor progressionSeminars in Cancer Biology, 2008
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Why do cancers have high aerobic glycolysis?Nature Reviews Cancer, 2004